Meta Platforms Falls 4% on Trial Risk With Costs Up 55%, Free Cash Flow Down to $784M
Meta Platforms fell 4% as trial risk coincided with a 55% rise in costs and free cash flow dropping to $784M. The setup shifts near-term focus from Meta’s 22.2% revenue growth to litigation exposure and cash-flow pressure.
Meta Platforms' shares fell 4% amid concerns over trial risk, alongside a 55% increase in costs and a decline in free cash flow to $784M.
The company's FY2025 results show revenue of $201.0B, up 22.2% year over year, with a 30.1% net margin and diluted EPS of $23.49. Those figures provide a substantial operating base, but the legal risk and cost growth may affect forward earnings and cash generation.
Key questions remain about the trial's scope and timing, any potential liability or remedy, and the drivers behind the cost increase. Future guidance and earnings commentary should clarify whether the $784M cash-flow figure is a temporary period effect or part of a broader deterioration.
Meta Platforms (META) fell 4% as costs rose 55% and free cash flow fell to $784M amid trial risk.
The immediate pressure is a combination of a 4% share-price decline, trial risk, and costs up 55%, with free cash flow down to $784M. META’s $201.0B of FY2025 revenue, 22.2% growth, and 30.1% net margin provide a meaningful counterweight, but the available facts do not establish that the legal and cash-flow concerns are resolved.
A clear trial outcome, a company explanation showing the $784M free-cash-flow figure is temporary, or evidence that costs normalize would weaken the downside setup.
CoverageSource: Yahoo Finance · Published here TUE, AUG 18 · 11:58 AM ET · 2 reports · 2 publishers in this record · latest listed: ZeroHedge · TUE, AUG 18 · 11:58 AM ETHow this is decided →
File photo · Meta’s headquarters, Menlo Park · Mar 2022 · LPS.1 · CC0 · Source & licenseEarlier context and later coverage are dated relative to this report. Automatically linked reports may cover a broader event.
No later reports linked yet.
Follow this story to find new evidence in your Following desk.
Price context does not establish that the story caused the move.
META retains a substantial operating base, with FY2025 revenue of $201.0B growing 22.2% year over year and a 30.1% net margin.
The near-term bear case is stronger on the reported facts: trial risk, costs up 55%, free cash flow down to $784M, and a 4% share-price decline point to simultaneous legal and financial pressure.
Kept as written · your side, if you take one, is graded privately against licensed closes after 10 trading days · nothing here is advice · How the Wire is made →